Ruth Franklin Yale University
1 protocol

Michael Zhang Molecular and Cellular Biology Department, University of Texas at Dallas, USA
2 protocols

Will Liao Genomics, New York Genome Center, USA
2 protocols

Weiming Ouyang Center for Drug Evaluation and Research, U.S. Food and Drug Administration, USA
2 protocols

Ming O. Li
  • Immunology Program, Memorial Sloan Kettering Cancer Center, USA
Research focus
  • Immunology
  • 3 Author merit
3 Protocols published
Determining Leukocyte Origins Using Parabiosis in the PyMT Breast Tumor Model
Authors:  Ruth A. Franklin and Ming O. Li, date: 08/20/2015, view: 9011, Q&A: 0
Tumors develop in a complex microenvironment alongside numerous cell types that impact their survival. Immune cells make up a large proportion of these accessory cells and many are known to promote tumor progression. Macrophages, in particular, are ...
Murine in vivo CD8+ T Cell Killing Assay
Authors:  Myoungjoo V. Kim, Weiming Ouyang, Will Liao, Michael Q. Zhang and Ming O. Li, date: 07/05/2014, view: 17428, Q&A: 0
Antigen-specific killing ability of effector CD8+ T cells is critical for protective immunity against infection. Here, we describe in vivo cytotoxic T cell assay to examine effector function of antigen-specific CD8+ T ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.